SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention after a sharp breakout to a 52-week high, with traders focused on heavy call buying and positioning ahead of the Q3 report. Buyout and short-squeeze theories are circulating, but remain speculation; others point to BRIUMVIs sales growth as the underlying driver.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Roots Hyundai Secure+ partnership is drawing attention after the product was identified as powered by Root, with traders focused on its potential to expand embedded, dealership-based insurance sales. Bulls see Hyundai and Kias vehicle sales as a significant distribution opportunity, while skeptics question how quickly the rollout can translate into policy growth amid recent concerns about declining policies in force.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is drawing attention ahead of its quarterly results, with traders focused on GMV and take rate as well as whether payments-heavy growth can offset margin pressure and rising credit costs. The discussion is split between hopes for a strong report and concerns about the recent pullback and earnings risk.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA submission for sonelokimab in hidradenitis suppurativa has put FDA acceptance and the review timeline at the center of discussion. Traders are split between optimism about the drugs potential and a possible partnership or acquisition, and concerns about regulatory risk, competition, and the cost of commercializing it independently.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1983 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere is drawing attention after strong quarterly results, higher full-year guidance and a dividend increase, fueling bullish momentum and fresh-high chatter. Some traders are taking profits and options positioning is mixed, reflecting caution after the run-up.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results are driving the sharp rally, with traders highlighting growth in Dupixent and Eylea HD and the stocks breakout to a new high. The reaction is broadly bullish, though some note that declining legacy Eylea sales and biosimilar competition remain risks.

TRON (TRX) is a cryptocurrency launched in 2018. TRON has a current supply of 95,022,365,191.094644 with 95,022,375,662.737444 in circulation. The last known price of TRON is 0.30232528 USD and is down -8.04 over the last 24 hours. It is currently trading on 1389 active market(s) with $1,465,217,312.79 traded over the last 24 hours. More information can be found at https://trondao.org/.

Tron

TRON is drawing attention for its steady price action, with traders debating whether consolidation and technical support point to further gains or continued stagnation. Some bullish posts also cite the networks stablecoin-transfer activity, while others remain frustrated by the coins slow performance.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

Speculation about XRP ETF demand and regulatory clarity is keeping the Bitwise XRP ETF in focus, with traders citing potential approvals and fund inflows while debating whether the ETFs performance will track XRP. Some holders also say they mistook the fund ticker for the XRP token, adding confusion about which asset they own.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirms strong quarterly results and better-than-expected outlook, followed by analyst upgrades, have driven attention. Traders are split after the initial earnings rally reversed sharply: some see profit-taking despite solid growth, while others point to a one-time tax benefit, elevated valuation, and rate and consumer-credit concerns.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owls Q3 results beat expectations, and traders are highlighting growth in assets under management, fee-related earnings, and managements outlook for future fee growth and dividend coverage. Bulls see room for a valuation recovery, while skeptics remain focused on private-credit redemption concerns and put-heavy options activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?

Affirm Upgraded To Outperform As Wolfe Sees ‘More Compelling’ Valuation After Strong Q4

Equity

According to TheFly, Wolfe Research turned more constructive on Affirm after its fiscal fourth-quarter results, arguing that the company’s valuation has become more compelling.

CoreWeave Announces The Launch Of Physical AI Field Engineering – A Look At Some Key Highlights

 The launch builds on CoreWeave’s acquisition of Monolith AI, which focused on using machine learning for complex engineering and physics problems.

ONON Stock Plunges To 2-Year Lows In Record Single-Day Crash After Guidance Cut, Revenue Miss 

Co-CEO David Allemann said On Holding is winning over what it calls the “movement class,” consumers who view fitness as part of their identity.


WULF Stock Snaps 7-Session Losing Streak On $19B Deal With Anthropic — What Investors Need To Know

TeraWulf expects to initially generate about $19 billion in contracted revenue from the Anthropic lease, with the first power delivery expected in the second half of 2026.

CPNG Stock Surges In Best Day Since Late 2022 As Coupang Data Breach Fine Lands Milder Than Expected

South Korea’s Personal Information Protection Commission (PIPC) has imposed administrative fines totaling around  $410 million on its Korean subsidiary, Coupang Corp, the company said. 

DJT Stock Flat After The Truth Social Firm Reports Q1 Loss of $405.9M

The firm reported total assets of $2.2 billion for the first quarter ended March.

iShares Trust - iShares Russell Mid-Cap Growth ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Wolfe continues to view Affirm as a structural winner, sets target price at $80</li><li>Affirm stock’s risk/reward is now more favorable, says the firm according to TheFly.</li><li>The company’s revenue in the fourth quarter grew 33% to $1.17 billion, beating FiscalAI's estimate.</li></ul>Affirm Holdings, Inc. (AFRM) was upgraded to 'Outperform' from 'Peer Perform' at Wolfe Research, with the firm setting a $90 price target and pointing to a more favorable risk/reward setup, according to TheFly.Affirm’s valuation has become “more compelling” at current levels since what the analyst described as a “strong” fiscal fourth-quarter (Q4) report, per TheFly. The firm also reiterated its view that Affirm remains a “structural winner.”<a href="https://stocktwits.com/symbol/AFRM">AFRM stock</a> was up more than 2% in Monday’s premarket, on track to extend previous session’s gain of 5%.<h2 class="st-heading-2">Why Affirm's Q4 Impressed Analysts</h2>Affirm’s "strong" Q4 results provide some context for Wolfe’s view. The fintech company's Q4 gross merchandise volume (GMV) increased 36% year over year to $14.1 billion. Its revenue grew 33% to $1.17 billion, beating FiscalAI's estimate by 5%.&nbsp;The firm's adjusted operating income rose 49% to $353 million, and adjusted operating margin expanded to 30% from 27% a year earlier.&nbsp;Growth was also broadening beyond traditional checkout integrations. Data showed that Affirm's Direct-to-consumer (D2C) GMV rose 49% to $4.7 billion, driven by Affirm Card GMV, which more than doubled to $2.8 billion. Active Affirm Card consumers also more than doubled to 5.2 million.<h2 class="st-heading-2">Affirm Targets Further Growth In FY27</h2>For fiscal 2027, Affirm expects more than $64 billion in GMV, up from approximately $49.4 billion in fiscal 2026. The company also forecasts an operating margin above 14.5% and an adjusted operating margin above 30.5%. For the first quarter, Affirm guided revenue to $1.19 billion to $1.22 billion and GMV to $13.7 billion to $14.0 billion.Wolfe’s upgrade therefore comes after a quarter that combined rapid transaction growth with higher profitability, while the company is guiding for further GMV expansion and margin improvement in fiscal 2027.<h2 class="st-heading-2">AFRM Stock: What Is Retail Mood</h2>Meanwhile, retail investor sentiment around AFRM stock remained ‘bearish’ on Stocktwits.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_09_14_170352_06f005a8d5.png" alt="Screenshot 2026-09-14 170352.png" width="831" height="475"><figcaption>AFRM stock retail sentiment on September 14 as of 7:30 a.m. ET | Source: Stocktwits</figcaption></figure>So far this year, Affirm shares have fallen over 3%, underperforming the benchmark S&amp;P 500, which has risen nearly 12% during this period.Read More:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/viasat-space42-plan-to-build-2800-satellite-d2d-network-through-new-venture-equatys/cZtl6NVRBRl">Viasat, Space42 Plan To Build 2,800-Satellite D2D Network Through New Venture Equatys</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, an Affirm Holdings Inc. logo is seen on a smartphone in a hand. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Affirm Holdings, Inc. (AFRM) was upgraded to 'Outperform' from 'Peer Perform' at Wolfe Research, with the firm setting a $90 price target and pointing to a more favorable risk/reward setup, according to TheFly.

Affirm Is A ‘Structural Winner,’ Wolfe Says — Upgrades AFRM Stock On ‘More Compelling’ Valuation

iShares Russell Mid-Cap Growth ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$131.64
Prev Close	$136.35
Open	$133.55
Dividend Yield	N/A
50-Day Moving Average	$138.46
Beta	N/A
Avg. Volume	750,430.50
PE Ratio	N/A

52-Week High	$148.29
52-Week Low	$122.94
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

IWP Fundamentals